The FDA Needs to Step Up!
This is an excerpt from the paper...
Pharmaceuticals that improve the health of individuals and improve quality of life are good for society. Regulation of those pharmaceuticals by government regulatory agencies like the Food and Drug Administration (FDA) is also good for society. However, a few years back the FDA eased regulatory requirements on direct-to-consumer (DTC) marketing and promotion of pharmaceuticals. Such advertisements have made popular antidepressant drugs like Zoloft generate $1.8 billion annually for Pfizer, a leading drug manufacturer (McMains 6). Nevertheless, such advertisements in the face of loosened regulatory controls have made DTC promotions shape public perception of pharmaceuticals and themselves, often for the worse due to misleading and outright false claims by manufacturers. When such claims are discovered by the FDA, pharmaceutical manufacturers receive merely a warning and six months to change the advertisements. As such, the public health is in jeopardy from lax regulation of DTC promotion, demanding the call from the FDA to increase sanctions and penalties against pharmaceutical manufacturers guilty of providing false or misleading information in DTC promotions. The happy ads of Zoloft, an antidepressant drug, and its main rival, Prozac, along with other DTC advertisements, have shifted public perception about illnesses from depression to impotence. However, critics argue that pharmaceutical companies spends tens of millions
. . .
Some common words found in the essay are:
Third FDA, Administration FDA, Zoloft Pfizer, Cokeö Napoli, Prozac DTC, Lorraine Bracco, Rx Remedy, Introduction Pharmaceuticals, Advertising Age, TV Napoli, dtc advertisements, public health, dtc promotions, public perception, napoli 3, pharmaceutical manufacturers, advertisements public health, false misleading, misleading outright, outright false, manufacturers guilty, pharmaceutical manufacturers guilty, misleading outright false,
Approximate Word count = 959
Approximate Pages = 4 (250 words per page)
More Essays on
The FDA Needs to Step Up!
|